skip to main content

Rogel Cancer Center receives $50M gift to revolutionize pancreatic cancer care, research

The gift will create the Rogel and Blondy Center for Pancreatic Cancer in honor of Max Rogel and Allen Blondy, Richard and Susan Rogel’s fathers, both of whom died from cancer. It will provide support for clinical care and translational research, playing to the strengths of the Rogel Cancer Center’s current robust team of 60 doctors and scientists from 10 departments already working in this area.

David Smith retires with a legacy of compassionate patient care

After 28 years at the University of Michigan, David Smith, M.D., will retire later this fall.

Faster, more sensitive lung cancer detection from a blood draw

Capturing nanoscale ‘packages’ that cancer cells send out, twisting gold nanoparticles use light to distinguish healthy patients from lung cancer patients.

Research points to potential new treatment for aggressive prostate cancer subtype

In two separate papers, U-M researchers describe how a gene alteration drives prostate cancer and a potential degrader that stops it

New law regulating out-of-pocket drug spending saves cancer patients more than $7,000 a year

The Inflation Reduction Act’s limit on Medicare Part D spending leads to significant savings for patients prescribed oral chemotherapy

Histotripsy liver tumor trial successful, early clinical adoption recommended

Used as a local treatment method for liver tumors, the procedure had a 95% success rate

Researchers develop enhanced communication framework for cancer clinics

Authors account for both verbal and nonverbal communication among doctors, medical staff and cancer patients

Researchers identify factor that drives prostate cancer-causing genes

Factor previously known to play a role in advanced cancer is fundamental in early stages of cancer development

Pages